SLC2A4 and chronic myelogenous leukemia, BCR-ABL1 positive: We did, however, observe a down‐regulation of INSR after 90 min and a differential regulation of the insulin‐regulated glucose transporter 4 (GLUT4) after 30 and 60 min of treatment with 500 μM CML, indicating an impact of CML treatment on glucose homeostasis on a genetic level.